BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced its support for The Joint Commission’s recent Sentinel Alert recommendations for the “Safe use of opioids in hospitals.”
